These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35134813)

  • 21. Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies.
    Montesinos I; Gruson D; Kabamba B; Dahma H; Van den Wijngaert S; Reza S; Carbone V; Vandenberg O; Gulbis B; Wolff F; Rodriguez-Villalobos H
    J Clin Virol; 2020 Jul; 128():104413. PubMed ID: 32403010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sars-Cov-2 Infection Screening Using Two Serological Testing Methods.
    Arinola OG; Edem VF; Rahamon SK; Yaqub SA; Fashina AO; Alonge TO
    Niger J Physiol Sci; 2020 Dec; 35(2):117-121. PubMed ID: 34009193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays.
    Valdivia A; Torres I; Latorre V; Francés-Gómez C; Albert E; Gozalbo-Rovira R; Alcaraz MJ; Buesa J; Rodríguez-Díaz J; Geller R; Navarro D
    Eur J Clin Microbiol Infect Dis; 2021 Mar; 40(3):485-494. PubMed ID: 33404891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limited specificity of commercially available SARS-CoV-2 IgG ELISAs in serum samples of African origin.
    Emmerich P; Murawski C; Ehmen C; von Possel R; Pekarek N; Oestereich L; Duraffour S; Pahlmann M; Struck N; Eibach D; Krumkamp R; Amuasi J; Maiga-Ascofaré O; Rakotozandrindrainy R; Asogun D; Ighodalo Y; Kann S; May J; Tannich E; Deschermeier C
    Trop Med Int Health; 2021 Jun; 26(6):621-631. PubMed ID: 33666297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum IgG anti-SARS-CoV-2 Binding Antibody Level Is Strongly Associated With IgA and Functional Antibody Levels in Adults Infected With SARS-CoV-2.
    Ye X; Angelo LS; Nicholson EG; Iwuchukwu OP; Cabral de Rezende W; Rajan A; Aideyan LO; McBride TJ; Bond N; Santarcangelo P; Rayford YJ; Ferlic-Stark L; Fragoso S; Momin Z; Liu H; Truong K; Lopez B; Conner ME; Rice AP; Kimata JT; Avadhanula V; Piedra PA
    Front Immunol; 2021; 12():693462. PubMed ID: 34691016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of serum IgM and IgG antibodies in COVID-19 patients by enzyme linked immunosorbent assay.
    Zhou C; Bu G; Sun Y; Ren C; Qu M; Gao Y; Zhu Y; Wang L; Sun L; Liu Y
    J Med Virol; 2021 May; 93(5):2857-2866. PubMed ID: 33331654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections.
    Huber T; Steininger P; Irrgang P; Korn K; Tenbusch M; Diesch K; Achenbach S; Kremer AE; Werblow M; Vetter M; Bogdan C; Held J
    Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1983-1997. PubMed ID: 34109500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serological assay for anti-SARS-CoV-2 antibodies improves sensitivity of diagnosis of COVID-19 patients.
    Rostamzadeh D; Mortezagholi S; Alinejad M; Jooya SR; Eskandarian M; Metvaei A; Vafaei S; Aboulghasemi H; Younesi V; Shabani M
    Med Microbiol Immunol; 2021 Dec; 210(5-6):283-289. PubMed ID: 34564742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance assessment of seven SARS-CoV-2 IgG enzyme-linked immunosorbent assays.
    Deshpande K; Pt U; Kaduskar O; Vijay N; Rakhe A; Vidhate S; Khutwad K; Deshpande GR; Tilekar B; Saka S; Gadekar K; Patil R; Yadav P; Potdar V; Gurav Y; Gupta P; Kaur H; Narayan J; Sapkal G; Abraham P
    J Med Virol; 2021 Dec; 93(12):6696-6702. PubMed ID: 34331713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a Surrogate Enzyme-Linked Immunosorbent Assay-Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation With Immunoglobulin G Commercial Serology Assays.
    Nandakumar V; Profaizer T; Lozier BK; Elgort MG; Larragoite ET; Williams ESCP; Solis-Leal A; Lopez JB; Berges BK; Planelles V; Rychert J; Slev PR; Delgado JC
    Arch Pathol Lab Med; 2021 Oct; 145(10):1212-1220. PubMed ID: 34181714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients.
    Chansaenroj J; Yorsaeng R; Posuwan N; Puenpa J; Sudhinaraset N; Chirathaworn C; Poovorawan Y
    Virol J; 2021 Mar; 18(1):52. PubMed ID: 33750394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a multiplexed coronavirus antigen array for detection of SARS-CoV-2 specific IgG in COVID-19 convalescent plasma.
    Huey L; Andersen G; Merkel PA; Morrison TE; McCarthy M; DomBourian MG; Annen K; Dawson ED; Rowlen KL; Knight V
    J Immunol Methods; 2021 Oct; 497():113104. PubMed ID: 34303688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Method To Prevent SARS-CoV-2 IgM False Positives in Gold Immunochromatography and Enzyme-Linked Immunosorbent Assays.
    Wang Q; Du Q; Guo B; Mu D; Lu X; Ma Q; Guo Y; Fang L; Zhang B; Zhang G; Guo X
    J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32277023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG.
    Krüttgen A; Cornelissen CG; Dreher M; Hornef M; Imöhl M; Kleines M
    J Clin Virol; 2020 Jul; 128():104394. PubMed ID: 32416599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic.
    Canetti D; Dell'Acqua R; Riccardi N; Della Torre L; Bigoloni A; Muccini C; Bruzzesi E; Ranzenigo M; Chiurlo M; Racca S; Galli C; Castagna A; Tambussi G; Lazzarin A
    New Microbiol; 2020 Oct; 43(4):161-165. PubMed ID: 33135083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serological Evaluation of Human Antibodies of the Immunoglobulin Class A and G Against SARS-CoV-2 in Serum Collected in Newfoundland and Labrador.
    Needle R; Gilbert L; Zahariadis G; Yu Y; Dalton-Kenny H; Russell RS; Wang P; Donovan C; Hookey S; Jiao L
    Viral Immunol; 2021 Apr; 34(3):182-189. PubMed ID: 33739895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Humoral immunological kinetics of severe acute respiratory syndrome coronavirus 2 infection and diagnostic performance of serological assays for coronavirus disease 2019: an analysis of global reports.
    Emeribe AU; Abdullahi IN; Shuwa HA; Uzairue L; Musa S; Anka AU; Adekola HA; Bello ZM; Rogo LD; Aliyu D; Haruna S; Usman Y; Muhammad HY; Gwarzo AM; Nwofe JO; Chiwar HM; Okwume CC; Animasaun OS; Fasogbon SA; Olayemi L; Ogar C; Emeribe CH; Ghamba PE; Awoniyi LO; Musa BOP
    Int Health; 2022 Jan; 14(1):18-52. PubMed ID: 33620427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitivity and Specificity of Anti-SARS-CoV-2 Detection Kits - Comparison and Agreement between Fifteen Different Assays.
    Kanani F; Jamal S; Khowaja S; Kaleem B; Anis S; Iftikhar S; Khursheed N; Baig Ansari N
    Jpn J Infect Dis; 2022 Jan; 75(1):16-23. PubMed ID: 34053957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of SARS-CoV-2 Specific Antibodies in Recovered Patients by Different ELISA Kits.
    Fereidouni A; Safari H; Rezapoor H; Mahmoudzadeh S; Fereidouni M
    Iran J Immunol; 2023 Sep; 20(3):374-381. PubMed ID: 37395262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of Commercial SARS-CoV-2 Immunoassays in a Nigerian Population.
    Ige F; Hamada Y; Steinhardt L; Iriemenam NC; Uwandu M; Greby SM; Aniedobe M; Salako BL; Rangaka MX; Abubakar I; Audu R
    Microbiol Spectr; 2021 Oct; 9(2):e0068021. PubMed ID: 34612691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.